US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

AstraZeneca PLC

69.67

+0.10000.14%

Volume:5.11M

Turnover:358.97M

Market Cap:216.07B

PE:30.96

High:70.80

Open:70.24

Low:69.62

Close:69.57

Loading ...

Overview Company News Filings

AstraZeneca (AZN) Receives a Buy from Bernstein

AstraZeneca PLC Stock Falls Monday, Underperforms Market

Astrazeneca-Amgen Asthma Treatment Reduces Nasal Polyps, Surgery Rates in Phase III Trial

MT Newswires Live

Lilly's Jaypirca Gets CHMP Nod for 2nd Leukemia Indication in Europe

Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire

Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps

Is AstraZeneca PLC (AZN) the Best Weight Loss Drug Stock to Buy According to Analysts?

Here's Why Astrazeneca (AZN) Gained But Lagged the Market Today

Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More

Astrazeneca's Breast Cancer Drug Recommended for Approval in EU

MT Newswires Live

AstraZeneca, Daiichi Sankyo’s Enhertu recommended for approval in EU

AstraZeneca PLC Stock Rises Thursday, Outperforms Market

Snowflake Expands Microsoft, OpenAI Partnership: Will Include Other Prominent Models Like Anthropic's Claude, Meta's Llama, And DeepSeek

AstraZeneca data ‘positive’ for Olema’s palazestrant, says H.C. Wainwright

AstraZeneca PLC (AZN): One of the Best Vaccine Stocks to Buy According to Hedge Funds

AstraZeneca's Breast-Cancer Drug Results Seen as Positive Surprise -- Market Talk

Astrazeneca Says Interim Data From Breast Cancer Therapy Study Shows Promise

MT Newswires Live

AstraZeneca breast cancer drug shows positive results, shares up

Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial

AstraZeneca (AZN) Gets a Buy from Bernstein

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AZN/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZN\",,,,,undefined,":{"symbol":"AZN","market":"US","secType":"STK","nameCN":"AstraZeneca PLC","latestPrice":69.67,"timestamp":1745865346985,"preClose":69.57,"halted":0,"volume":5107063,"delay":0,"floatShares":3089219511,"shares":3101273230,"eps":2.25,"marketStatus":"Trading","change":0.1,"latestTime":"04-28 14:35:48 EDT","open":70.24,"high":70.8,"low":69.62,"amount":358974564.53397495,"amplitude":0.016961,"askPrice":69.68,"askSize":75,"bidPrice":69.66,"bidSize":760,"shortable":3,"etf":0,"ttmEps":2.25,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745870400000},"marketStatusCode":2,"adr":1,"adrRate":0.5,"listingDate":737179200000,"exchange":"NASDAQ","adjPreClose":69.57,"dividendRate":0.022248,"preHourTrading":{"tag":"盘前","latestPrice":70.26,"preClose":69.57,"latestTime":"09:29 EDT","volume":27431,"amount":1922411.825906,"timestamp":1745846999999},"postHourTrading":{"tag":"盘后","latestPrice":69.73,"preClose":69.57,"latestTime":"19:46 EDT","volume":129193,"amount":8982746.698,"timestamp":1745624790687},"volumeRatio":1.33891,"optionData":{"bulkOrders":[{"symbol":"AZN","call":true,"expireDate":1747368000000,"strike":"72.0","timestamp":1745847953209,"price":1.44,"volume":4000,"amount":576000,"type":"+"},{"symbol":"AZN","call":false,"expireDate":1747368000000,"strike":"70.0","timestamp":1745854439148,"price":1.88,"volume":3000,"amount":564000,"type":"+"}]},"impliedVol":0.3511,"impliedVolPercentile":0.932},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZN\",,,,,undefined,":{"symbol":"AZN","floatShares":3089219511,"roa":"7.88%","roe":"17.59%","lyrEps":2.269354,"volumeRatio":1.33891,"shares":3101273230,"dividePrice":1.55,"high":70.8,"amplitude":0.016961,"preClose":69.57,"low":69.62,"week52Low":61.24,"pbRate":"5.30","psRate":"4.00","week52High":87.675,"institutionHeld":0.1738,"latestPrice":69.67,"committee":0.820359,"eps":2.25,"divideRate":0.022248,"volume":5107063,"delay":0,"ttmEps":2.25,"open":70.24,"prevYearClose":65.52,"prevWeekClose":69.57,"prevMonthClose":73.5,"prevQuarterClose":73.5,"fiveDayClose":66.9,"twentyDayClose":73.79,"sixtyDayClose":71.24},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZN\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516864148","title":"AstraZeneca (AZN) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2516864148","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516864148?lang=en_us&edition=fundamental","pubTime":"2025-03-04 15:56","pubTimestamp":1741074975,"startTime":"0","endTime":"0","summary":"In a report released today, Justin Smith from Bernstein maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of £190...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-buy-from-bernstein?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-buy-from-bernstein?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2462157665.USD","BK4568","AZN","LU2456880835.USD","LU2236285917.USD","BK4588","LU0320765992.SGD","LU2417539215.USD","BK4007","LU1829250122.USD","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2516656948","title":"AstraZeneca PLC Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2516656948","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516656948?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:01","pubTimestamp":1741021260,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC slipped 0.9% to SEK1,607.00 Monday on what proved to be an overall favorable trading session for the stock market, with the OMX Nordic 40 Index rising 0.7% to 2,715.54.This was the stock's second consecutive day of losses.The company closed SEK192.00 short of its 52-week high of SEK1,799.00, which the company reached on September 3, 2024.Trading volume was 375,268, compared to the 50-day average trading volume of 285,045.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"gpt_icon":0},{"id":"2516180687","title":"Astrazeneca-Amgen Asthma Treatment Reduces Nasal Polyps, Surgery Rates in Phase III Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2516180687","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516180687?lang=en_us&edition=fundamental","pubTime":"2025-03-03 19:59","pubTimestamp":1741003188,"startTime":"0","endTime":"0","summary":"Astrazeneca  said Saturday the full results from the Phase III trial showed Tezspire or tezepelumab, an asthma treatment jointly developed with Amgen , led to significant reductions in nasal polyp severity, surgery requirements, and systemic corticosteroid use for patients with chronic rhinosinusitis with nasal polyps, compared with placebo.At week 52, Tezspire improved the co-primary endpoints, reducing Nasal Polyp Score by -2.065 and nasal congestion by -1.028 compared with placebo, with benefits observed as early as weeks four and two respectively.These findings were published in the New England Journal of Medicine and presented at the American Academy of Allergy Asthma & Immunology and World Allergy Organization Joint Congress in San Diego, California on Saturday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","BK4599","LU1571399168.USD","LU1829250122.USD","IE00B4R5TH58.HKD","BK4139","LU1983299246.USD","LU0320765992.SGD","BK4581","BK4134","LU2456880835.USD","AMGN","BK4568","LU0058720904.USD","LU0109394709.USD","LU0289739699.SGD","IE0002141913.USD","LU2462157665.USD","LU2236285917.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4585","LU0889565916.HKD","LU2417539215.USD","LU2112291526.USD","AZN","BK4566","III","LU0122379950.USD","LU2242646821.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU2242652126.USD","BK4007","BK4588","BK4534","SG9999001440.SGD","LU0868494617.USD","BK4533","LU1057294990.SGD"],"gpt_icon":0},{"id":"2516680448","title":"Lilly's Jaypirca Gets CHMP Nod for 2nd Leukemia Indication in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2516680448","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516680448?lang=en_us&edition=fundamental","pubTime":"2025-03-03 18:50","pubTimestamp":1740999000,"startTime":"0","endTime":"0","summary":"Eli Lilly and Company LLY announced that theEuropean Medicines Agency'sCommittee for Medicinal Productsfor Human Use  has given a positive opinion recommending approval of its BTK inhibitor, Jaypirca , for treating relapsed or refractory chronic lymphocytic leukemia  in patients who have been previously treated with a BTK inhibitor in the European Union. The approval was based on data from the phase III BRUIN CLL-321 study.The European Commission is expected to give its decision in a couple of months. Jaypirca is already approved in the EU on a conditional basis for the treatment of adult patients with relapsed or refractory mantle cell lymphoma  who have been previously treated with a BTK inhibitor.Lilly’s shares have risen 16.2% in the past year against a decline of 0.9% for the industry.Jaypirca was approved in the United States for treating CLL or small lymphocytic lymphoma in patients who have received at least two lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lillys-jaypirca-gets-chmp-nod-105000850.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1720051017.SGD","LU0256863811.USD","LU1059921491.USD","LU1267930813.SGD","IE0009355771.USD","LU1917777945.USD","SG9999002224.SGD","LU2087621335.USD","IE00BVYPNV92.GBP","LU1244550577.SGD","LU0345769631.USD","LU2237443382.USD","LU1720051108.HKD","SG9999001176.USD","LU0882574055.USD","SGXZ51526630.SGD","LU2347655156.SGD","AZN","LU0058720904.USD","GB00BDT5M118.USD","LU2430703095.HKD","LLY","LU1064131342.USD","LU0320765646.SGD","IE000M9KFDE8.USD","LU1989772840.SGD","IE0004445239.USD","SG9999013999.USD","LU1196500208.SGD","LU0354030438.USD","JNJ","SGXZ99366536.SGD","IE00BVYPNW00.USD","LU0198837287.USD","ABBV","SG9999015945.SGD","LU0128525929.USD","CHMP","LU1066051498.USD","LU0061475181.USD","LU0320765059.SGD","LU1244550221.USD","LU1267930730.SGD","LU1935042991.SGD","LU2129689605.HKD","LU2129689514.USD","LU2237443622.USD","LU2361044865.SGD","SG9999001176.SGD","SG9999003800.SGD"],"gpt_icon":1},{"id":"2516517473","title":"Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire","url":"https://stock-news.laohu8.com/highlight/detail?id=2516517473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516517473?lang=en_us&edition=fundamental","pubTime":"2025-03-02 22:10","pubTimestamp":1740924616,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) and AstraZeneca (AZN) announced full results from the Phase 3, registrational WAYPOINT trial demonstrating that TEZSPIRE significantly...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-results-from-phase-3-waypoint-trial-on-tezspire?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-astrazeneca-announce-results-from-phase-3-waypoint-trial-on-tezspire?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1571399168.USD","LU1061106388.HKD","BK4581","LU0320765992.SGD","LU2417539215.USD","LU1023059063.AUD","LU0058720904.USD","LU2456880835.USD","LU2462157665.USD","LU2242652126.USD","LU1829250122.USD","SG9999001440.SGD","LU0289739699.SGD","BK4534","IE00BFTCPJ56.SGD","BK4139","BK4585","IE0002141913.USD","LU0122379950.USD","BK4566","LU2112291526.USD","LU1983299246.USD","LU2236285917.USD","IE00BJJMRZ35.SGD","BK4533","LU1057294990.SGD","IE00B2B36J28.USD","BK4599","LU0889565916.HKD","LU0868494617.USD","LU0109394709.USD","AZN","LU2242646821.SGD","BK4568","AMGN","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4007","IE0009355771.USD","BK4588"],"gpt_icon":0},{"id":"2516168564","title":"Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps","url":"https://stock-news.laohu8.com/highlight/detail?id=2516168564","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516168564?lang=en_us&edition=fundamental","pubTime":"2025-03-02 06:30","pubTimestamp":1740868200,"startTime":"0","endTime":"0","summary":"TEZSPIRE significantly reduced nasal congestion, polyp size and nearly eliminated the need for surgery in patients with chronic rhinosinusitis with nasal polyps. WAYPOINT data published in New England Journal of Medicine and highlighted as late-breaking oral presentation at AAAAI/WAO 2025. WILMINGTON, Del., March 01, 2025----Full results from the positive Phase III WAYPOINT trial showed AstraZeneca and Amgen’s TEZSPIRE  significantly reduced nasal polyp severity, the need for subsequent surgery, and systemic corticosteroid use in patients with chronic rhinosinusitis with nasal polyps  compared to placebo.1,2 These data were published in the New England Journal of Medicine and presented today as a late-breaking oral presentation at the American Academy of Allergy Asthma & Immunology /World Allergy Organization  Joint Congress in San Diego, CA.1,2. Statistically significant and clinically meaningful improvements were observed across all key secondary outcomes assessed in the overall tria","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/positive-results-tezspire-phase-iii-223000077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0516423174.USD","LU0251143029.SGD","TSLP","LU0261945553.USD","SG9999002406.SGD","SG9999013486.USD","LU2045819591.USD","LU0979878070.USD","BK4551","BK4585","LU2236285917.USD","SG9999002679.SGD","TSS","SG9999014492.USD","BK4535","SG9999002414.USD","SG9999002620.SGD","LU0516422952.EUR","BK4568","BK4566","LU2417539215.USD","LU0320765992.SGD","III","LU0572939691.SGD","SG9999014484.SGD","LU0532188223.SGD","LU1242518857.USD","SG9999013460.SGD","SGXZ58947870.SGD","SG9999004360.SGD","SG9999002604.SGD","LU0516422440.USD","LU0516422366.SGD","SG9999006266.SGD","IE0034224299.USD","LU0737861269.HKD","BK4134","LU0889565916.HKD","SG9999001135.SGD","BK4554","LU2456880835.USD","SG9999013478.USD","AZN","LU0516423091.SGD","LU1242518931.SGD","LU0048573645.USD","FL","BK4503","LU1829250122.USD"],"gpt_icon":1},{"id":"2516934566","title":"Is AstraZeneca PLC (AZN) the Best Weight Loss Drug Stock to Buy According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516934566","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516934566?lang=en_us&edition=fundamental","pubTime":"2025-03-02 03:55","pubTimestamp":1740858925,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where AstraZeneca PLC  stands against other best weight loss drug stocks to buy according to analysts.Global Surge in Obesity Medication Market Driven by GLP-1 Drugs. Morgan Stanley Research has increased its prediction for the global market for obesity medications from $77 billion to $105 billion by 2030 in light of this demand increase. In 2023, brand-name obesity drugs brought in almost $6 billion.According to JP Morgan Research, obesity and diabetes will drive the GLP-1 market’s growth to $100 billion by 2030. By that year, there may be 30 million GLP-1 users in the US or around 9% of the total population. Increased demand for obesity medications will benefit some industries, such as biotech, while posing problems for others, such as the food and beverage sector.The latest generation of GLP-1 medications are being hailed by some as “miracle d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazeneca-plc-azn-best-weight-195525180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1829250122.USD","LU0889565916.HKD","LU0225283273.USD","LU2089283258.USD","USJW.SI","LU1162221912.USD","SQQQ","BK4585","LU2417539215.USD","TQQQ","LU1720051108.HKD","LU0795875086.SGD","TSYW.SI","LU0267386448.USD","LU2456880835.USD","LU1363072403.SGD","MNQmain","LU2028103732.USD","NVIW.SI","BK4516","NQmain","LU2133065610.SGD","LU2089284900.SGD","LU1989772840.SGD","QID","LU0109394709.USD","BK4581","LU2462157665.USD","LU2271345857.HKD","IE00BZ1G4Q59.USD","BK4568","LU1668664300.SGD","LU0314104364.USD","LU0158827948.USD","LU2357305700.SGD","LU2023251221.USD","QLD","USAW.SI","LU0106261372.USD",".IXIC","AZN","BK4534","IE00BKVL7J92.USD","LU0795875169.SGD","LU0158827781.USD","PSQ","LU1548497426.USD","LU0320765646.SGD","LU1732799900.SGD"],"gpt_icon":1},{"id":"2516589697","title":"Here's Why Astrazeneca (AZN) Gained But Lagged the Market Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2516589697","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516589697?lang=en_us&edition=fundamental","pubTime":"2025-03-01 07:15","pubTimestamp":1740784508,"startTime":"0","endTime":"0","summary":"Astrazeneca  ended the recent trading session at $76.21, demonstrating a +0.74% swing from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of 1.59%. Meanwhile, the Dow gained 1.39%, and the Nasdaq, a tech-heavy index, added 1.63%.Heading into today, shares of the pharmaceutical had gained 6.19% over the past month, outpacing the Medical sector's loss of 0.63% and the S&P 500's loss of 2.42% in that time.Market participants will be closely following the financial results of Astrazeneca in its upcoming release. The company's earnings per share  are projected to be $1.09, reflecting a 5.83% increase from the same quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $13.58 billion, reflecting a 7.07% rise from the equivalent quarter last year.Investors might also notice recent changes to analyst estimates for Astrazeneca. Recent revisions tend to reflect the latest near-term business trends. With thi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-astrazeneca-azn-gained-231508471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AZN","BK4585","LU2462157665.USD","LU1829250122.USD","BK4007","BK4588","LU0320765992.SGD","LU0889565916.HKD","LU2417539215.USD","LU2236285917.USD","LU0109394709.USD","LU2456880835.USD","BK4568"],"gpt_icon":0},{"id":"2516236371","title":"Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2516236371","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516236371?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:46","pubTimestamp":1740753960,"startTime":"0","endTime":"0","summary":"This week, Eli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants. AstraZeneca’s AZN phase III study on breast cancer candidate, camizestrant, meets its primary endpoint. The FDA granted priority review to a supplemental biologics license application  seeking approval for expanded use of Merck’s MRK blockbuster drug, Keytruda, in head and neck squamous cell carcinoma .Here's a recap of the week’s most important stories.LLY to Invest $27B to Expand U.S. Manufacturing Sites. The study’s key secondary endpoints were time to second disease progression  and overall survival . The secondary endpoints were immature at the time of this interim analysis. However, an improving trend in PFS2 was observed for the camizestrant combination arm. The study will continue to assess the secondary endpoints.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-lly-ups-144600821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2361044949.HKD","SG9999002232.USD","MRK","LU1035775433.USD","LU0211331839.USD","LU0965509101.SGD","OS","BK4516","LU1023059063.AUD","LU2357305700.SGD","LU0256863902.USD","LU1571399168.USD","LU1720051108.HKD","LU2461242641.AUD","IE0004445239.USD","LU1585245621.USD","LU1064131342.USD","LU0320765489.SGD","LU1623119135.USD","LU1814569148.SGD","LU1868837300.USD","LLY","LU1988902786.USD","LU2211815571.USD","LU1366192091.USD","SG9999001176.USD","LU0094547139.USD","LU0471298694.HKD","LU0203201768.USD","LU0861579265.USD","BK4007","LU1430594728.SGD","LU0672654240.SGD","LU1267930730.SGD","LU1551013425.SGD","LU0203347892.USD","LU0114720955.EUR","BK4568","LU0320765992.SGD","LU2468319806.SGD","LU0265550946.USD","LU2324357040.USD","IE00B4R5TH58.HKD","LU0820561818.USD","LU1066051225.USD","LU0106261372.USD","AZN","LU0198837287.USD","LU0096364046.USD","LU1929549753.HKD"],"gpt_icon":1},{"id":"2514661324","title":"Astrazeneca's Breast Cancer Drug Recommended for Approval in EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2514661324","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514661324?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:38","pubTimestamp":1740749902,"startTime":"0","endTime":"0","summary":"Astrazeneca  said Friday its Enhertu drug has been recommended for approval in the European Union for treatment of adults with HER2 low or HER2 ultralow metastatic breast cancer following at least one endocrine therapy.Enhertu is a antibody drug conjugate discovered by Daiichi Sankyo and being jointly developed and commercialized by the two companies.The Committee for Medicinal Products for Human Use of the European Medicines Agency, which gave the recommendation for approval, based its opinion on results from a phase 3 trial that evaluated the efficacy and safety of the drug, Astrazeneca said.The recommendation will be reviewed by the European Commission, which has the authority to grant marketing authorization for the drug, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","BK4588","BK4007","LU2236285917.USD","LU1829250122.USD","AZN","LU2417539215.USD","LU2462157665.USD","BK4156","BK4585","LU0109394709.USD","LU0320765992.SGD","LU2456880835.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2514321468","title":"AstraZeneca, Daiichi Sankyo’s Enhertu recommended for approval in EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2514321468","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514321468?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:15","pubTimestamp":1740748553,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) and Daiichi Sankyo’s (DSNKY) trastuzumab deruxtecan has been recommended for approval in the European Union as a monotherapy for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-daiichi-sankyos-enhertu-recommended-for-approval-in-eu?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-daiichi-sankyos-enhertu-recommended-for-approval-in-eu?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2456880835.USD","LU1829250122.USD","BK4568","DSNKY","LU0889565916.HKD","LU0109394709.USD","BK4156","AZN","LU2236285917.USD","LU2462157665.USD","BK4007","LU2417539215.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2514238027","title":"AstraZeneca PLC Stock Rises Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2514238027","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514238027?lang=en_us&edition=fundamental","pubTime":"2025-02-28 01:01","pubTimestamp":1740675660,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC rose 1.3% to SEK1,630.00 Thursday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.8% to 2,700.54.This was the stock's fifth consecutive day of gains.The company closed SEK169.00 short of its 52-week high of SEK1,799.00, which the company reached on September 3, 2024.Trading volume was 338,232, compared to the 50-day average trading volume of 282,092.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN"],"gpt_icon":0},{"id":"2514820664","title":"Snowflake Expands Microsoft, OpenAI Partnership: Will Include Other Prominent Models Like Anthropic's Claude, Meta's Llama, And DeepSeek","url":"https://stock-news.laohu8.com/highlight/detail?id=2514820664","media":"Benzinga","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514820664?lang=en_us&edition=fundamental","pubTime":"2025-02-27 16:52","pubTimestamp":1740646322,"startTime":"0","endTime":"0","summary":"Snowflake unveiled its deeper partnership with Microsoft Corp during its earnings call and introduced its new AI agent Cortex.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/02/43999325/snowflake-doubles-down-on-ai-expands-openai-partnership-microsoft-365-teams-to-have-new-cortex-agents","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNOW","STT","MSFT","AZN","SPY"],"gpt_icon":1},{"id":"2514653568","title":"AstraZeneca data ‘positive’ for Olema’s palazestrant, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2514653568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514653568?lang=en_us&edition=fundamental","pubTime":"2025-02-27 01:20","pubTimestamp":1740590425,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) shared positive interim data from the ongoing SERENA-6 Phase 3 trail evaluating camizestrant and CDK4/6 inhibitors as a first-lin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-data-positive-for-olemas-palazestrant-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-data-positive-for-olemas-palazestrant-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0109394709.USD","LU0320765992.SGD","LU2456880835.USD","LU2462157665.USD","LU2236285917.USD","LU0889565916.HKD","LU2417539215.USD","BK4585","BK4568","LU1829250122.USD","BK4007","AZN"],"gpt_icon":0},{"id":"2514579378","title":"AstraZeneca PLC (AZN): One of the Best Vaccine Stocks to Buy According to Hedge Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2514579378","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514579378?lang=en_us&edition=fundamental","pubTime":"2025-02-27 00:05","pubTimestamp":1740585911,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AstraZeneca PLC  stands against the other best vaccine stocks to buy now.What Will Trump’s Tariffs Mean for the Pharma Industry?On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of their month-long delay on their implementation. When asked about the postponed tariffs at a White House press conference, President Trump said:. “The tariffs are going forward on time, on schedule.”He claimed that foreign nations have been taking advantage of the US in “just about everything,” reiterating his plans to impose “reciprocal tariffs.”“So the tariffs will go forward, yes, and we’re going to make up a lot of territory,” Trump said.We recently discussed what Trump’s tariffs could mean for the healthcare","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazeneca-plc-azn-one-best-160511784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1829250122.USD","QLD","PSQ","LU2236285917.USD","AZN","LU2462157665.USD","TQQQ","LU0320765992.SGD","BK4568","MNQmain","USJW.SI","QID","SQQQ","NQmain","LU0109394709.USD","BK4007","TSYW.SI","USAW.SI","LU2417539215.USD","BK4588",".IXIC","LU0889565916.HKD","NVIW.SI","BK4585","LU2456880835.USD"],"gpt_icon":1},{"id":"2514185927","title":"AstraZeneca's Breast-Cancer Drug Results Seen as Positive Surprise -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2514185927","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514185927?lang=en_us&edition=fundamental","pubTime":"2025-02-26 22:59","pubTimestamp":1740581940,"startTime":"0","endTime":"0","summary":"1459 GMT - AstraZeneca's trial results for breast cancer pill Camizestrant are a material positive surprise and clear the first of its major late-stage catalysts for this year, Barclays analysts say in a note. The British pharma giant's results showed the drug candidate helped patients live for longer without their disease worsening. AstraZeneca guides for a more than $5 billion peak sales potential, whereas Barclays anticipates $3.6 billion. The company indicated it would release most key results in 2H, leading to the analysts expecting publication in the middle of the summer. Shares are up 0.1% at 119.46 pounds.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU1829250122.USD","LU2462157665.USD","BK4588","LU2236285917.USD","LU0889565916.HKD","LU0320765992.SGD","LU2417539215.USD","AZN","BK4007","LU2456880835.USD","LU0109394709.USD","BK4585"],"gpt_icon":0},{"id":"2514858701","title":"Astrazeneca Says Interim Data From Breast Cancer Therapy Study Shows Promise","url":"https://stock-news.laohu8.com/highlight/detail?id=2514858701","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514858701?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:59","pubTimestamp":1740578355,"startTime":"0","endTime":"0","summary":"AstraZeneca  said Wednesday that an interim analysis of the phase 3 trial of its experimental therapy, camizestrant, combined with a cyclin-dependent kinase inhibitor showed statistically significant and clinically meaningful improvement in progression-free survival in certain breast cancer patients compared to standard of care.Although key secondary endpoints such as time-to-second disease progression and overall survival were not fully mature, the combination therapy showed a trend toward improvement, the company said.The drugmaker said the trial will continue to assess secondary endpoints as planned.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZN","BK4585","LU2462157665.USD","LU1829250122.USD","BK4007","BK4588","LU0320765992.SGD","LU0889565916.HKD","LU2417539215.USD","LU2236285917.USD","LU0109394709.USD","LU2456880835.USD","BK4568"],"gpt_icon":0},{"id":"2514980831","title":"AstraZeneca breast cancer drug shows positive results, shares up","url":"https://stock-news.laohu8.com/highlight/detail?id=2514980831","media":"Investing.com","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514980831?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:04","pubTimestamp":1740571462,"startTime":"0","endTime":"0","summary":"Investing.com -- AstraZeneca  announced on Wednesday that its experimental breast cancer treatment, camizestrant, helped extend survival without disease progression in patients with an advanced form of the illness during a late-stage clinical trial.The company’s US-listed shares rose 1% in premarket trading Wednesday.According to the company’s interim analysis, camizestrant, when combined with a standard treatment designed to block proteins that drive tumor growth, showed a positive impact on progression-free survival as a first-line therapy.The trial, known as \"SERENA-6,\" evaluated the combination in patients with hormone receptor-positive, HER2-negative advanced breast cancer carrying a specific genetic mutation.AstraZeneca said the drug’s safety profile remained consistent with what is already known for each medicine, with no new safety concerns identified and very few patients discontinuing treatment.Analysts project that camizestrant could generate $1.5 billion in sales by 2030.Ba","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazeneca-breast-cancer-drug-shows-120422345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2417539215.USD","BK4568","CAGR","BK4588","AZN","LU2456880835.USD","PIII","LU0320765992.SGD","BK4196","BK4585","LU1829250122.USD","LU0109394709.USD","LU2462157665.USD","BK4159","LU2236285917.USD","BK4007","LU0889565916.HKD"],"gpt_icon":0},{"id":"2514831987","title":"Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2514831987","media":"Business Wire","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514831987?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:00","pubTimestamp":1740571200,"startTime":"0","endTime":"0","summary":"First and only next-generation oral SERD and complete ER antagonist to demonstrate 1st-line benefit in combination with widely approved CDK4/6 inhibitors. The key secondary endpoints of time to second disease progression  and overall survival  were immature at the time of this interim analysis. However, the camizestrant combination demonstrated a trend toward improvement in PFS2. The trial will continue as planned to further assess key secondary endpoints.Susan Galbraith, Executive Vice President, Oncology Hematology R&D, AstraZeneca, said: \"These impressive results demonstrate the versatility of camizestrant in combination with all the widely approved CDK4/6 inhibitors to provide a well-tolerated new potential treatment option in the first-line setting for the one in three patients with HR-positive, HER2-negative advanced breast cancer whose tumors develop ESR1 mutations during","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/camizestrant-demonstrated-highly-statistically-significant-120000062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2236285917.USD","BK4097","LU1829250122.USD","BK4134","BK4203","OS","BK4588","LU0320765992.SGD","LU2456880835.USD","LU2417539215.USD","BK4568","BK4225","PFS","BK4211","BK4585","III","LU2462157665.USD","LU0109394709.USD","LU0889565916.HKD","HR","BK4007","BK4195","AZN"],"gpt_icon":0},{"id":"2514882435","title":"AstraZeneca (AZN) Gets a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2514882435","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514882435?lang=en_us&edition=fundamental","pubTime":"2025-02-26 17:58","pubTimestamp":1740563896,"startTime":"0","endTime":"0","summary":"In a report released on February 24, Florent Cespedes from Bernstein maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-bernstein-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-gets-a-buy-from-bernstein-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2417539215.USD","BK4568","LU2456880835.USD","LU1829250122.USD","BK4585","AZN","BK4007","LU2236285917.USD","LU0320765992.SGD","LU2462157665.USD","BK4588","LU0889565916.HKD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZN\",params:#limit:5,,,undefined,":[{"date":"2025-04-29","symbol":"AZN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.1,"defaultRemindTime":1745913600000,"name":null,"time":"Pre-Market","dateTimestamp":1745899200000,"actualEps":null},{"date":"2025-02-21","symbol":"AZN","amount":1.05,"announcedDate":"2025-02-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-21","defaultRemindTime":1740148200000,"name":"阿斯利康","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-24","payableDate":"2025-02-21","currency":"USD","dateTimestamp":1740114000000,"payDate":"2025-03-24"},{"market":"US","date":"2025-02-06","symbol":"AZN","fiscalQuarterEnding":"2024/12","expectedEps":1.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":1.05},{"market":"US","date":"2024-11-12","symbol":"AZN","fiscalQuarterEnding":"2024/09","expectedEps":1.01,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":1.04},{"date":"2024-08-09","symbol":"AZN","amount":0.5,"announcedDate":"2024-07-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-09","defaultRemindTime":1723210200000,"name":"阿斯利康","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-09","payableDate":"2024-08-09","currency":"USD","dateTimestamp":1723176000000,"payDate":"2024-09-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZN\",market:\"US\",,,undefined,":[{"executeDate":"2016-02-17","recordDate":"2016-02-19","paymentDate":"2016-03-21","value":0.93,"currency":"USD"},{"executeDate":"2016-08-10","recordDate":"2016-08-12","paymentDate":"2016-09-12","value":0.44,"currency":"USD"},{"executeDate":"2017-02-15","recordDate":"2017-02-17","paymentDate":"2017-03-20","value":0.93,"currency":"USD"},{"executeDate":"2017-08-09","recordDate":"2017-08-11","paymentDate":"2017-09-11","value":0.44,"currency":"USD"},{"executeDate":"2018-02-15","recordDate":"2018-02-16","paymentDate":"2018-03-19","value":0.93,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3077,"buy":0.6154,"hold":0.0769,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6154,"analysts":13,"updateTime":1744430400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AZN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AZN","date":"2025-04-25","current":30.491371,"percent":0.125616,"low":-196.839437,"twenty":32.783239,"median":40.827536,"eighty":71.444046,"high":1968.240717,"avg":105.712969,"sd":364.333485,"marketCap":214506794307},"quantilePoints":[{"date":"2020-05-01","current":88.65014,"twenty":33.810018,"median":41.769955,"eighty":63.887506,"marketCap":134925513904.98},{"date":"2020-05-08","current":91.757593,"twenty":33.810018,"median":41.817639,"eighty":64.047299,"marketCap":139655056517.41},{"date":"2020-05-15","current":90.61471,"twenty":33.810018,"median":41.817639,"eighty":64.3314,"marketCap":137915587379.85},{"date":"2020-05-22","current":94.488642,"twenty":33.810018,"median":41.817639,"eighty":64.766526,"marketCap":143811713694.17},{"date":"2020-05-29","current":91.303819,"twenty":33.810018,"median":41.828728,"eighty":64.996903,"marketCap":138964412815.2},{"date":"2020-06-05","current":92.409801,"twenty":33.810018,"median":41.905749,"eighty":65.495146,"marketCap":140647717765.34},{"date":"2020-06-12","current":88.601773,"twenty":33.810018,"median":42.104217,"eighty":67.891019,"marketCap":134851898165.53},{"date":"2020-06-19","current":90.514417,"twenty":33.810018,"median":42.174792,"eighty":68.436024,"marketCap":137762942001.19},{"date":"2020-06-26","current":89.870253,"twenty":33.810018,"median":42.303223,"eighty":68.737983,"marketCap":136782525607.4},{"date":"2020-07-02","current":92.427925,"twenty":33.810018,"median":42.437213,"eighty":69.042583,"marketCap":140675302740.49},{"date":"2020-07-10","current":92.718659,"twenty":33.810018,"median":42.708877,"eighty":69.343604,"marketCap":141117798226.05},{"date":"2020-07-17","current":99.322235,"twenty":33.810018,"median":42.808295,"eighty":69.589283,"marketCap":151168442039.6},{"date":"2020-07-24","current":95.408114,"twenty":33.810018,"median":42.978118,"eighty":69.943808,"marketCap":145211149956.52},{"date":"2020-07-31","current":68.468512,"twenty":33.810018,"median":43.076217,"eighty":70.038737,"marketCap":147070361983.16},{"date":"2020-08-07","current":67.562997,"twenty":33.810018,"median":43.188144,"eighty":70.038737,"marketCap":145125318295.06},{"date":"2020-08-14","current":67.098371,"twenty":33.810018,"median":43.384918,"eighty":70.038737,"marketCap":144127300491.42},{"date":"2020-08-21","current":67.475084,"twenty":33.810018,"median":43.553809,"eighty":70.038737,"marketCap":144936481167.69},{"date":"2020-08-28","current":67.998044,"twenty":33.810018,"median":43.671628,"eighty":70.038737,"marketCap":146059798146.29},{"date":"2020-09-04","current":64.280901,"twenty":33.810018,"median":43.915425,"eighty":70.038737,"marketCap":138075374440.25},{"date":"2020-09-11","current":65.824326,"twenty":33.810018,"median":43.983884,"eighty":70.038737,"marketCap":141390652748.24},{"date":"2020-09-18","current":69.221855,"twenty":33.810018,"median":44.188968,"eighty":70.038737,"marketCap":148688544713.05},{"date":"2020-09-25","current":66.553733,"twenty":33.810018,"median":44.383729,"eighty":70.038737,"marketCap":142957418917.99},{"date":"2020-10-02","current":66.662663,"twenty":33.810018,"median":44.572948,"eighty":70.038737,"marketCap":143191400097.07},{"date":"2020-10-09","current":66.953055,"twenty":33.810018,"median":44.833877,"eighty":70.038737,"marketCap":143815161541.86},{"date":"2020-10-16","current":64.839687,"twenty":33.810018,"median":45.033151,"eighty":70.038737,"marketCap":139275648167.86},{"date":"2020-10-23","current":63.312144,"twenty":33.810018,"median":45.462301,"eighty":70.038737,"marketCap":135994485474.97},{"date":"2020-10-30","current":61.469046,"twenty":33.810018,"median":45.948999,"eighty":70.038737,"marketCap":132035510158.58},{"date":"2020-11-06","current":58.661785,"twenty":33.810018,"median":46.231724,"eighty":69.998502,"marketCap":146478476162.56},{"date":"2020-11-13","current":59.760079,"twenty":33.810018,"median":46.231724,"eighty":69.851997,"marketCap":149220915141.86},{"date":"2020-11-20","current":58.100671,"twenty":33.810018,"median":46.231724,"eighty":69.58094,"marketCap":145077376135.16},{"date":"2020-11-27","current":54.42849,"twenty":33.810018,"median":46.231724,"eighty":69.343948,"marketCap":135907938310.72},{"date":"2020-12-04","current":56.342788,"twenty":33.810018,"median":46.231724,"eighty":69.221855,"marketCap":140687941772.31},{"date":"2020-12-11","current":56.704271,"twenty":33.810018,"median":46.231724,"eighty":69.042583,"marketCap":141590563706.2},{"date":"2020-12-18","current":53.257556,"twenty":33.810018,"median":46.231724,"eighty":68.737983,"marketCap":132984116876.27},{"date":"2020-12-24","current":51.42954,"twenty":33.810018,"median":46.231724,"eighty":68.628075,"marketCap":128419562786.63},{"date":"2020-12-31","current":52.566621,"twenty":33.810018,"median":46.231724,"eighty":68.505005,"marketCap":131258852901.26},{"date":"2021-01-08","current":53.297492,"twenty":33.810018,"median":46.231724,"eighty":68.340916,"marketCap":133083838200.57},{"date":"2021-01-15","current":54.250512,"twenty":33.810018,"median":46.231724,"eighty":68.152058,"marketCap":135463529694.98},{"date":"2021-01-22","current":55.860251,"twenty":33.810018,"median":46.231724,"eighty":67.837301,"marketCap":139483046174.97},{"date":"2021-01-29","current":54.013362,"twenty":33.810018,"median":46.231724,"eighty":67.597089,"marketCap":134871364067.04},{"date":"2021-02-05","current":52.499585,"twenty":33.810018,"median":46.231724,"eighty":67.475084,"marketCap":131091464291.89},{"date":"2021-02-12","current":42.481646,"twenty":33.810018,"median":46.026399,"eighty":67.083797,"marketCap":135771337221.21},{"date":"2021-02-19","current":41.615797,"twenty":33.810018,"median":45.920036,"eighty":66.813746,"marketCap":133004089019.12},{"date":"2021-02-26","current":39.726772,"twenty":33.810018,"median":45.20917,"eighty":66.662663,"marketCap":126966763856.01},{"date":"2021-03-05","current":38.882507,"twenty":33.808324,"median":44.906662,"eighty":66.12361,"marketCap":124268492718.61},{"date":"2021-03-12","current":39.690846,"twenty":33.808324,"median":44.636711,"eighty":65.784088,"marketCap":126851941792.25},{"date":"2021-03-19","current":40.522698,"twenty":33.808324,"median":44.473388,"eighty":65.224549,"marketCap":129510542855.95},{"date":"2021-03-26","current":41.19428,"twenty":33.810018,"median":44.279927,"eighty":64.996903,"marketCap":131656922094.72},{"date":"2021-04-01","current":40.740961,"twenty":33.810018,"median":44.17727,"eighty":64.775083,"marketCap":130208113091.4},{"date":"2021-04-09","current":41.073847,"twenty":33.808324,"median":43.952764,"eighty":64.342644,"marketCap":131272013845.01},{"date":"2021-04-16","current":41.895286,"twenty":33.808324,"median":43.829519,"eighty":64.272386,"marketCap":133897332132.29},{"date":"2021-04-23","current":43.015928,"twenty":33.808324,"median":43.622491,"eighty":64.049177,"marketCap":137478904953.89},{"date":"2021-04-30","current":35.178221,"twenty":33.808324,"median":43.552363,"eighty":63.927524,"marketCap":139903784314.35},{"date":"2021-05-07","current":35.713855,"twenty":33.808324,"median":43.372927,"eighty":63.927524,"marketCap":142034002903.86},{"date":"2021-05-14","current":36.578305,"twenty":33.808324,"median":43.217296,"eighty":63.927524,"marketCap":145471921978.13},{"date":"2021-05-21","current":38.04253,"twenty":33.808324,"median":43.055022,"eighty":63.927524,"marketCap":151295142362.51},{"date":"2021-05-28","current":37.667421,"twenty":33.808324,"median":42.981334,"eighty":63.927524,"marketCap":149803331492.43},{"date":"2021-06-04","current":37.668709,"twenty":33.808324,"median":42.916976,"eighty":63.927524,"marketCap":149808456584.88},{"date":"2021-06-11","current":38.832052,"twenty":33.808324,"median":42.773046,"eighty":63.927524,"marketCap":154435068990.32},{"date":"2021-06-18","current":38.18588,"twenty":33.808324,"median":42.622329,"eighty":63.927524,"marketCap":151865244858.85},{"date":"2021-06-25","current":39.023576,"twenty":33.808324,"median":42.398874,"eighty":63.927524,"marketCap":155196763903.69},{"date":"2021-07-02","current":39.976605,"twenty":33.808324,"median":42.174589,"eighty":63.927524,"marketCap":158986959728.24},{"date":"2021-07-09","current":39.480288,"twenty":33.808324,"median":42.080378,"eighty":63.927524,"marketCap":157013104025.95},{"date":"2021-07-16","current":37.956603,"twenty":33.808324,"median":41.899376,"eighty":63.927524,"marketCap":150953410117.19},{"date":"2021-07-23","current":45.441176,"twenty":33.808324,"median":41.888722,"eighty":63.927524,"marketCap":180719559415.33},{"date":"2021-07-30","current":47.231592,"twenty":33.810018,"median":41.892004,"eighty":63.861793,"marketCap":178110332974.09},{"date":"2021-08-06","current":46.469553,"twenty":33.810018,"median":41.892004,"eighty":63.713835,"marketCap":175236684168.41},{"date":"2021-08-13","current":47.972744,"twenty":33.810018,"median":41.892004,"eighty":63.551982,"marketCap":180905220248.64},{"date":"2021-08-20","current":48.844093,"twenty":33.810018,"median":41.892004,"eighty":63.422693,"marketCap":184191075201.21},{"date":"2021-08-27","current":48.365293,"twenty":33.810018,"median":41.892004,"eighty":62.883701,"marketCap":182385516153.02},{"date":"2021-09-03","current":48.463129,"twenty":33.811774,"median":41.895286,"eighty":62.612474,"marketCap":182754457617.81},{"date":"2021-09-10","current":46.494,"twenty":33.811774,"median":41.895286,"eighty":62.43589,"marketCap":175328870596.71},{"date":"2021-09-17","current":45.556592,"twenty":33.811774,"median":41.895286,"eighty":61.949531,"marketCap":171793907663.64},{"date":"2021-09-24","current":49.669587,"twenty":33.811774,"median":41.895286,"eighty":61.607974,"marketCap":187304013407.33},{"date":"2021-10-01","current":48.824353,"twenty":33.811774,"median":41.895286,"eighty":61.248398,"marketCap":184116632093.75},{"date":"2021-10-08","current":49.800513,"twenty":33.811774,"median":41.895286,"eighty":61.020009,"marketCap":187797735584.04},{"date":"2021-10-15","current":49.71937,"twenty":33.811774,"median":41.895286,"eighty":60.739134,"marketCap":187491745853.75},{"date":"2021-10-22","current":50.871053,"twenty":33.811774,"median":41.895286,"eighty":60.537147,"marketCap":191834739729.65},{"date":"2021-10-29","current":51.128224,"twenty":33.81353,"median":41.897331,"eighty":60.445661,"marketCap":192804535774.89},{"date":"2021-11-05","current":51.586876,"twenty":33.81353,"median":41.897331,"eighty":60.445661,"marketCap":194534108269.15},{"date":"2021-11-12","current":124.32333,"twenty":33.81353,"median":41.917192,"eighty":60.445661,"marketCap":182879619363.67},{"date":"2021-11-19","current":120.23438,"twenty":33.81353,"median":42.14268,"eighty":60.685883,"marketCap":176864773031.09},{"date":"2021-11-26","current":117.962901,"twenty":33.81353,"median":42.190627,"eighty":60.88723,"marketCap":173523426730.59},{"date":"2021-12-03","current":114.058101,"twenty":33.81353,"median":42.459679,"eighty":61.11746,"marketCap":167779466800.21},{"date":"2021-12-10","current":114.181064,"twenty":33.81353,"median":42.699465,"eighty":61.452265,"marketCap":167960345018.33},{"date":"2021-12-17","current":118.980811,"twenty":33.81353,"median":42.837881,"eighty":61.891111,"marketCap":175020772922.72},{"date":"2021-12-23","current":121.330793,"twenty":33.81353,"median":42.933402,"eighty":62.081355,"marketCap":178477596827.59},{"date":"2021-12-31","current":123.748715,"twenty":33.81353,"median":43.007672,"eighty":62.499235,"marketCap":182034359116.88},{"date":"2022-01-07","current":120.050561,"twenty":33.815286,"median":43.097412,"eighty":62.953761,"marketCap":176594376318.68},{"date":"2022-01-14","current":123.058267,"twenty":33.815286,"median":43.234717,"eighty":63.424083,"marketCap":181018710009.44},{"date":"2022-01-21","current":124.994373,"twenty":33.815286,"median":43.372927,"eighty":63.548212,"marketCap":183866722078.34},{"date":"2022-01-28","current":123.976416,"twenty":33.815286,"median":43.552363,"eighty":63.706505,"marketCap":182369309247.62},{"date":"2022-02-04","current":118.184057,"twenty":33.815286,"median":43.622491,"eighty":63.860585,"marketCap":173848748288.24},{"date":"2022-02-11","current":1601.026247,"twenty":33.817042,"median":43.82776,"eighty":64.00879,"marketCap":179314939563.19},{"date":"2022-02-18","current":1654.401018,"twenty":33.817042,"median":43.939798,"eighty":64.169686,"marketCap":185292914010.65},{"date":"2022-02-25","current":1668.738174,"twenty":33.817042,"median":44.078325,"eighty":64.295473,"marketCap":186898675368.11},{"date":"2022-03-04","current":1586.663703,"twenty":33.817042,"median":44.224518,"eighty":64.600266,"marketCap":177706334684.76},{"date":"2022-03-11","current":1675.474001,"twenty":33.817042,"median":44.467018,"eighty":65.166625,"marketCap":187653088130.53},{"date":"2022-03-18","current":1738.306661,"twenty":33.817042,"median":44.572948,"eighty":65.784088,"marketCap":194690345992.99},{"date":"2022-03-25","current":1795.841809,"twenty":33.817042,"median":44.572948,"eighty":66.489581,"marketCap":201134282573.26},{"date":"2022-04-01","current":1827.083488,"twenty":33.817042,"median":44.572948,"eighty":66.698379,"marketCap":204633350610.8},{"date":"2022-04-08","current":1968.240717,"twenty":33.817042,"median":44.599854,"eighty":66.956295,"marketCap":220442960330.62},{"date":"2022-04-14","current":1903.633793,"twenty":33.817042,"median":44.664609,"eighty":67.127776,"marketCap":213206984758.84},{"date":"2022-04-22","current":1827.31022,"twenty":33.817042,"median":45.008047,"eighty":67.494417,"marketCap":204658744606.77},{"date":"2022-04-29","current":-195.561143,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":207881494412.78},{"date":"2022-05-06","current":-186.047843,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":197768857946.09},{"date":"2022-05-13","current":-183.445869,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":195002958947.03},{"date":"2022-05-20","current":-190.668769,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":202680901868.49},{"date":"2022-05-27","current":-194.54477,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":206801090657.37},{"date":"2022-06-03","current":-190.374978,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":202368602400.22},{"date":"2022-06-10","current":-176.891963,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":188036156437.33},{"date":"2022-06-17","current":-176.59081,"twenty":33.912759,"median":45.498884,"eighty":67.607761,"marketCap":187716030487.33},{"date":"2022-06-24","current":-193.054847,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":205217301659.23},{"date":"2022-07-01","current":-188.578174,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":200458598457.74},{"date":"2022-07-08","current":-193.728763,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":205933674494.87},{"date":"2022-07-15","current":-192.228519,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":204338915909.36},{"date":"2022-07-22","current":-188.718222,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":200607469952.86},{"date":"2022-07-29","current":-163.162978,"twenty":33.941221,"median":45.556592,"eighty":67.618433,"marketCap":204443212506.84},{"date":"2022-08-05","current":-161.84855,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":202796233583.46},{"date":"2022-08-12","current":-160.589567,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":201218726783.29},{"date":"2022-08-19","current":-164.33585,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":205912819247.31},{"date":"2022-08-26","current":-165.535736,"twenty":33.804057,"median":45.556592,"eighty":67.618433,"marketCap":207416276963.04},{"date":"2022-09-02","current":-151.980645,"twenty":33.793274,"median":45.556592,"eighty":67.618433,"marketCap":190431747964.03},{"date":"2022-09-09","current":-150.350821,"twenty":33.759854,"median":45.556592,"eighty":67.618433,"marketCap":188389579323.08},{"date":"2022-09-16","current":-142.971469,"twenty":33.462713,"median":45.556592,"eighty":67.618433,"marketCap":179143250929.75},{"date":"2022-09-23","current":-135.412757,"twenty":33.234819,"median":45.556592,"eighty":67.618433,"marketCap":169672185276.98},{"date":"2022-09-30","current":-137.024975,"twenty":33.070312,"median":45.556592,"eighty":67.618433,"marketCap":171692293015.61},{"date":"2022-10-07","current":-137.934582,"twenty":32.990313,"median":45.556592,"eighty":67.618433,"marketCap":172832030829.71},{"date":"2022-10-14","current":-136.189836,"twenty":32.851802,"median":45.556592,"eighty":67.618433,"marketCap":170645864409.42},{"date":"2022-10-21","current":-134.729179,"twenty":32.794598,"median":45.556592,"eighty":67.618433,"marketCap":168815662212.36},{"date":"2022-10-28","current":-145.085703,"twenty":32.578746,"median":45.556592,"eighty":67.618433,"marketCap":181792385725.21},{"date":"2022-11-04","current":-150.046253,"twenty":32.441126,"median":45.556592,"eighty":67.618433,"marketCap":188007955286.73},{"date":"2022-11-11","current":94.735808,"twenty":32.406054,"median":46.033505,"eighty":67.825263,"marketCap":193261049543.38},{"date":"2022-11-18","current":98.881438,"twenty":32.406054,"median":46.253226,"eighty":68.270745,"marketCap":201718134504.01},{"date":"2022-11-25","current":100.570487,"twenty":32.406054,"median":46.494,"eighty":68.630373,"marketCap":205163794032.47},{"date":"2022-12-02","current":104.001851,"twenty":32.406054,"median":46.662739,"eighty":69.183829,"marketCap":212163775968.3},{"date":"2022-12-09","current":106.087706,"twenty":32.406054,"median":47.149871,"eighty":69.716808,"marketCap":216418920541.74},{"date":"2022-12-16","current":102.978508,"twenty":32.406054,"median":47.231592,"eighty":77.51575,"marketCap":210076156888.69},{"date":"2022-12-23","current":102.942288,"twenty":32.406054,"median":47.744626,"eighty":80.277721,"marketCap":210002267642.7},{"date":"2022-12-30","current":102.667462,"twenty":32.406054,"median":47.889649,"eighty":84.998822,"marketCap":209441622638.71},{"date":"2023-01-06","current":107.816944,"twenty":32.458836,"median":48.074276,"eighty":86.203785,"marketCap":219946565887.33},{"date":"2023-01-13","current":108.069807,"twenty":32.750787,"median":48.137803,"eighty":87.690545,"marketCap":220462406785.54},{"date":"2023-01-20","current":105.346185,"twenty":32.842448,"median":48.225012,"eighty":88.132026,"marketCap":214906218177.77},{"date":"2023-01-27","current":99.91328,"twenty":32.990313,"median":48.365293,"eighty":89.493625,"marketCap":203823092868.29},{"date":"2023-02-03","current":97.194847,"twenty":33.091636,"median":48.590919,"eighty":89.958492,"marketCap":198277488061.49},{"date":"2023-02-10","current":64.79374,"twenty":34.704276,"median":48.67565,"eighty":90.227834,"marketCap":213041815934.3},{"date":"2023-02-17","current":64.947931,"twenty":34.925603,"median":48.824353,"eighty":90.227834,"marketCap":213548799709.69},{"date":"2023-02-24","current":62.505092,"twenty":34.952202,"median":48.879329,"eighty":90.227834,"marketCap":205516742935.99},{"date":"2023-03-03","current":60.884824,"twenty":35.166348,"median":49.034331,"eighty":90.227834,"marketCap":200189300543.79},{"date":"2023-03-10","current":60.817416,"twenty":35.244416,"median":49.259346,"eighty":90.227834,"marketCap":199967660996.94},{"date":"2023-03-17","current":62.038789,"twenty":35.50748,"median":49.397527,"eighty":90.227834,"marketCap":203983536730.65},{"date":"2023-03-24","current":63.847982,"twenty":35.636896,"median":49.622888,"eighty":90.227834,"marketCap":209932167388.35},{"date":"2023-03-31","current":65.498173,"twenty":35.705258,"median":49.69358,"eighty":90.221194,"marketCap":215357992309.98},{"date":"2023-04-06","current":68.570831,"twenty":35.757541,"median":49.714558,"eighty":90.221194,"marketCap":225460889410.27},{"date":"2023-04-14","current":70.200873,"twenty":35.964313,"median":49.945228,"eighty":90.227834,"marketCap":230820471067.89},{"date":"2023-04-21","current":71.517248,"twenty":36.054882,"median":50.706874,"eighty":90.227834,"marketCap":235148709402.74},{"date":"2023-04-27","current":48.542146,"twenty":36.18562,"median":50.911319,"eighty":90.227834,"marketCap":228390801103.1},{"date":"2023-05-05","current":49.347014,"twenty":36.268071,"median":50.945363,"eighty":90.234475,"marketCap":232177702207.76},{"date":"2023-05-12","current":49.504739,"twenty":36.37963,"median":50.979408,"eighty":90.241115,"marketCap":232919796188.45},{"date":"2023-05-19","current":49.107772,"twenty":36.442091,"median":51.05333,"eighty":90.273874,"marketCap":231052066290.14},{"date":"2023-05-26","current":47.846336,"twenty":36.591375,"median":51.060903,"eighty":90.299991,"marketCap":225117008406.37},{"date":"2023-06-02","current":48.462782,"twenty":36.80131,"median":51.068476,"eighty":90.326109,"marketCap":228017386013.05},{"date":"2023-06-09","current":48.413705,"twenty":36.956644,"median":51.09835,"eighty":90.352226,"marketCap":227786482533.35},{"date":"2023-06-16","current":49.548607,"twenty":37.011895,"median":51.09835,"eighty":90.352226,"marketCap":233126199438.55},{"date":"2023-06-23","current":47.927025,"twenty":37.145966,"median":51.128224,"eighty":90.378344,"marketCap":225496652662.89},{"date":"2023-06-29","current":46.686861,"twenty":37.277576,"median":51.128224,"eighty":90.378344,"marketCap":219661682991.5},{"date":"2023-07-07","current":42.266477,"twenty":37.450916,"median":51.137896,"eighty":90.382517,"marketCap":198863776215.19},{"date":"2023-07-14","current":44.543915,"twenty":37.668194,"median":51.147569,"eighty":90.38669,"marketCap":209579116648.77},{"date":"2023-07-20","current":45.272526,"twenty":37.899674,"median":51.147569,"eighty":90.38669,"marketCap":213007237009.48},{"date":"2023-07-28","current":46.8505,"twenty":38.043422,"median":51.198971,"eighty":90.390862,"marketCap":220431604774.28},{"date":"2023-08-04","current":34.891689,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":215037480780.58},{"date":"2023-08-11","current":35.26449,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":217335048660.17},{"date":"2023-08-18","current":34.16614,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":210565921407.54},{"date":"2023-08-25","current":33.869471,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":208737548997.49},{"date":"2023-09-01","current":34.101255,"twenty":38.067629,"median":51.257864,"eighty":90.399208,"marketCap":210166031129.92},{"date":"2023-09-08","current":34.014193,"twenty":38.076047,"median":51.265357,"eighty":90.402485,"marketCap":209629465144.03},{"date":"2023-09-15","current":34.144205,"twenty":38.076047,"median":51.265357,"eighty":90.402485,"marketCap":210430732865.46},{"date":"2023-09-22","current":34.173978,"twenty":38.142274,"median":51.271456,"eighty":90.405762,"marketCap":210614226640.52},{"date":"2023-09-29","current":34.077187,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":210017704350},{"date":"2023-10-06","current":33.461697,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":206224433900},{"date":"2023-10-13","current":33.700939,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":207698886830.05},{"date":"2023-10-20","current":31.854117,"twenty":38.185365,"median":51.277556,"eighty":90.40904,"marketCap":196316921973.67},{"date":"2023-10-27","current":30.825604,"twenty":38.239617,"median":51.294062,"eighty":90.41603,"marketCap":189978199121.01},{"date":"2023-11-03","current":31.446977,"twenty":38.239617,"median":51.294062,"eighty":90.41603,"marketCap":193807722775.81},{"date":"2023-11-10","current":32.576944,"twenty":38.185708,"median":51.294062,"eighty":90.41603,"marketCap":192073660849.91},{"date":"2023-11-17","current":33.492327,"twenty":38.038501,"median":51.294062,"eighty":90.41603,"marketCap":197470761267.37},{"date":"2023-11-24","current":33.532656,"twenty":37.946854,"median":51.294062,"eighty":90.41603,"marketCap":197708536718.25},{"date":"2023-12-01","current":33.915355,"twenty":37.668451,"median":51.294062,"eighty":90.41603,"marketCap":199964933886.19},{"date":"2023-12-08","current":33.457568,"twenty":37.464611,"median":51.286265,"eighty":90.415594,"marketCap":197265816339.95},{"date":"2023-12-15","current":34.186234,"twenty":37.210418,"median":51.286265,"eighty":90.415594,"marketCap":201562040512.73},{"date":"2023-12-22","current":34.744053,"twenty":37.103714,"median":51.286265,"eighty":90.415594,"marketCap":204850936396.91},{"date":"2023-12-29","current":35.502272,"twenty":37.004613,"median":51.294062,"eighty":90.41603,"marketCap":209321397367.75},{"date":"2024-01-05","current":35.915235,"twenty":36.741256,"median":51.301859,"eighty":90.416466,"marketCap":211756222293.47},{"date":"2024-01-12","current":36.28455,"twenty":36.334148,"median":51.301859,"eighty":90.416466,"marketCap":213933708276.37},{"date":"2024-01-19","current":35.054357,"twenty":36.147608,"median":51.316432,"eighty":90.416903,"marketCap":206680482585.36},{"date":"2024-01-26","current":35.21195,"twenty":35.750631,"median":51.301859,"eighty":90.416466,"marketCap":207609659830.59},{"date":"2024-02-02","current":34.611292,"twenty":35.488516,"median":51.301859,"eighty":90.416466,"marketCap":204068178014.97},{"date":"2024-02-09","current":32.042332,"twenty":35.415951,"median":51.301859,"eighty":90.416466,"marketCap":190812082322.82},{"date":"2024-02-16","current":33.046703,"twenty":35.234976,"median":51.301859,"eighty":90.416466,"marketCap":196793117826.02},{"date":"2024-02-23","current":33.625836,"twenty":35.160006,"median":51.301859,"eighty":90.416466,"marketCap":200241851316.37},{"date":"2024-03-01","current":33.150124,"twenty":34.950737,"median":51.294062,"eighty":90.41603,"marketCap":197408989034.17},{"date":"2024-03-08","current":33.961877,"twenty":34.884115,"median":51.294062,"eighty":90.41603,"marketCap":202242978023.88},{"date":"2024-03-15","current":34.178971,"twenty":34.843983,"median":51.294062,"eighty":90.41603,"marketCap":203535777995.74},{"date":"2024-03-22","current":34.569497,"twenty":34.797981,"median":51.294062,"eighty":90.41603,"marketCap":205861353801.33},{"date":"2024-03-28","current":35.138443,"twenty":34.738617,"median":51.294062,"eighty":90.41603,"marketCap":209249428257.93},{"date":"2024-04-05","current":35.017877,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":208531458010.87},{"date":"2024-04-12","current":36.040239,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":214619626779.03},{"date":"2024-04-19","current":35.516317,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":211499662791.19},{"date":"2024-04-26","current":36.676755,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":232200540199.91},{"date":"2024-05-03","current":36.8693,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":233419536058.18},{"date":"2024-05-10","current":37.90429,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":239972059656.37},{"date":"2024-05-17","current":37.573079,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":237875168240.39},{"date":"2024-05-24","current":38.271406,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":242296270130.04},{"date":"2024-05-31","current":38.035274,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":240801317006.26},{"date":"2024-06-07","current":39.311051,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":248878266840.98},{"date":"2024-06-14","current":39.080088,"twenty":34.71484,"median":51.294062,"eighty":90.41603,"marketCap":247416040543.47},{"date":"2024-06-21","current":38.711485,"twenty":34.712808,"median":51.301859,"eighty":90.416466,"marketCap":245082412423.47},{"date":"2024-06-28","current":38.258325,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":242213457601.51},{"date":"2024-07-05","current":37.686159,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":238591075664.77},{"date":"2024-07-12","current":38.775783,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":245489481019.61},{"date":"2024-07-15","current":38.484698,"twenty":34.703903,"median":51.387168,"eighty":90.437103,"marketCap":243646624421.22},{"date":"2024-08-02","current":38.76335,"twenty":34.59882,"median":51.492254,"eighty":90.59886,"marketCap":249635972195.12},{"date":"2024-08-09","current":38.89894,"twenty":34.59882,"median":51.294062,"eighty":90.59886,"marketCap":250509172617.5},{"date":"2024-08-16","current":40.397147,"twenty":34.59882,"median":51.060903,"eighty":90.59886,"marketCap":260157622811.64},{"date":"2024-08-23","current":41.20613,"twenty":34.59882,"median":50.717669,"eighty":90.59886,"marketCap":265367483505.69},{"date":"2024-08-30","current":42.055252,"twenty":34.59882,"median":50.035509,"eighty":90.59886,"marketCap":270835826209.18},{"date":"2024-09-06","current":40.0627,"twenty":34.59882,"median":49.699751,"eighty":90.59886,"marketCap":258003788372.74},{"date":"2024-09-13","current":37.541027,"twenty":34.59882,"median":49.61335,"eighty":90.59886,"marketCap":241764208376.59},{"date":"2024-09-20","current":37.638672,"twenty":34.59882,"median":49.509177,"eighty":90.59886,"marketCap":242393042178.33},{"date":"2024-09-27","current":37.625615,"twenty":34.59882,"median":49.286663,"eighty":90.59886,"marketCap":242308957210.11},{"date":"2024-10-04","current":37.048339,"twenty":34.59882,"median":49.111103,"eighty":90.59886,"marketCap":238591303207.03},{"date":"2024-10-11","current":36.952592,"twenty":34.59882,"median":48.955607,"eighty":90.59886,"marketCap":237974690511.11},{"date":"2024-10-18","current":37.277326,"twenty":34.59882,"median":48.824043,"eighty":90.59886,"marketCap":240065978538.81},{"date":"2024-10-25","current":36.219041,"twenty":34.59882,"median":48.705135,"eighty":90.59886,"marketCap":233250622910.59},{"date":"2024-10-31","current":34.214563,"twenty":34.574738,"median":48.556466,"eighty":90.59886,"marketCap":220341789337.11},{"date":"2024-11-08","current":30.94958,"twenty":34.409381,"median":48.405215,"eighty":90.61471,"marketCap":199315297141.26},{"date":"2024-11-15","current":30.278774,"twenty":34.310083,"median":48.308272,"eighty":90.61471,"marketCap":196660634447.86},{"date":"2024-11-22","current":31.513145,"twenty":34.186234,"median":48.222861,"eighty":90.61471,"marketCap":204677872404.93},{"date":"2024-11-29","current":32.112113,"twenty":34.16614,"median":48.127581,"eighty":90.61471,"marketCap":208568177906.67},{"date":"2024-12-06","current":32.437834,"twenty":34.130516,"median":47.956432,"eighty":90.61471,"marketCap":210683725873.77},{"date":"2024-12-13","current":31.735912,"twenty":34.077187,"median":47.36104,"eighty":90.61471,"marketCap":206124752986.75},{"date":"2024-12-20","current":30.747177,"twenty":33.965862,"median":47.158831,"eighty":90.61471,"marketCap":199702915335.92},{"date":"2024-12-27","current":31.253559,"twenty":33.915355,"median":46.947642,"eighty":90.61471,"marketCap":202991871173.56},{"date":"2025-01-03","current":31.292576,"twenty":33.861252,"median":46.643867,"eighty":90.61471,"marketCap":203245281002.46},{"date":"2025-01-10","current":32.234446,"twenty":33.727001,"median":46.406597,"eighty":90.65359,"marketCap":209362728493.97},{"date":"2025-01-17","current":31.94661,"twenty":33.648774,"median":45.807185,"eighty":90.65359,"marketCap":207493237604.76},{"date":"2025-01-24","current":32.550101,"twenty":33.596764,"median":45.422812,"eighty":90.65359,"marketCap":211412903531.46},{"date":"2025-01-31","current":33.75602,"twenty":33.533107,"median":44.889475,"eighty":90.65359,"marketCap":219245348015.01},{"date":"2025-02-07","current":31.815023,"twenty":33.517373,"median":44.556858,"eighty":90.65359,"marketCap":223818687137.12},{"date":"2025-02-14","current":32.356027,"twenty":33.43473,"median":43.745721,"eighty":90.65359,"marketCap":227624649448.94},{"date":"2025-02-21","current":32.60623,"twenty":33.370464,"median":43.206289,"eighty":90.41603,"marketCap":229384833994.16},{"date":"2025-02-28","current":33.297502,"twenty":33.297026,"median":42.86189,"eighty":90.196276,"marketCap":234247926833.79},{"date":"2025-03-07","current":34.342579,"twenty":33.296549,"median":42.266477,"eighty":89.763533,"marketCap":241600044097.11},{"date":"2025-03-14","current":34.223161,"twenty":33.289955,"median":41.916906,"eighty":89.650259,"marketCap":240759931866.61},{"date":"2025-03-21","current":33.174158,"twenty":33.275366,"median":41.821537,"eighty":89.650259,"marketCap":233380202105.67},{"date":"2025-03-28","current":32.611493,"twenty":33.192075,"median":41.337415,"eighty":89.650259,"marketCap":229421855281.37},{"date":"2025-04-04","current":31.260761,"twenty":33.125053,"median":41.199067,"eighty":89.650259,"marketCap":219919458662.82},{"date":"2025-04-11","current":28.594151,"twenty":33.037318,"median":41.064599,"eighty":89.636216,"marketCap":201159849729.73},{"date":"2025-04-17","current":29.581448,"twenty":33.006368,"median":40.989973,"eighty":88.809353,"marketCap":208105481337.82},{"date":"2025-04-25","current":30.491371,"twenty":32.783239,"median":40.827536,"eighty":71.444046,"marketCap":214506794307}],"updateTime":1745834648157}}}